Quality of life and depression in Parkinson's disease
- 1 October 2006
- journal article
- review article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 248 (1-2), 151-157
- https://doi.org/10.1016/j.jns.2006.05.030
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Citalopram Treatment of Depression in Parkinson's Disease: The Impact on Anxiety, Disability, and CognitionThe Journal of Neuropsychiatry and Clinical Neurosciences, 2004
- Factors impacting on quality of life in Parkinson's disease: Results from an international surveyMovement Disorders, 2002
- Allelic variation of serotonin transporter expression is associated with depression in Parkinson's diseaseMolecular Psychiatry, 2001
- Health-related quality of life in parkinson's disease: A study of outpatient clinic attendersMovement Disorders, 1997
- Effect of age at onset on frequency of depression in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Symptomatic effect of selegiline in de novo parkinsonian patientsMovement Disorders, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Deprenyl (selegiline) in combination treatment of Parkinson's diseaseActa Neurologica Scandinavica, 1983
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983